Highlights
1 patentProfile claimed by owner
About
Nano particles psychedelics in intranasal delivery for mental health conditions
Madrigal Mental Care is focused on using nanotechnology to accurately deliver psychedelic drugs for the treatment of mental health conditions such as post-traumatic stress disorder (PTSD).
The company's Nanovo intranasal spray is designed to deliver active, nanoencapsulated psychedelic substances directly to the brain for rapid, safe, and efficient uptake.
Madrigal utilizes molecules composed of psychedelic drugs such as psilocybin, ketamine, mescaline, MDMA, and more. By fundamentally changing the coding in the brain, rather than simply treating symptoms, the company is able to offer a transformative solution with minimal side effects.
Identity
| Name | Madrigal Mental Care |
|---|---|
| Slug | madrigal-mental-care |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkNy68qcIDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | South District |
| HQ city | Re'im |
| HQ address | Re'im, Israel |
Web & social
| Website | https://www.madrigal-psy.com/ |
|---|---|
| https://www.linkedin.com/company/81297063 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Materials & SubstancesNanomaterialsBiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticalsMedical Devices IndustryMedical Products
Business models
B2B
Tags
drug-developmenttreatmentsbiopharmaceuticalnanotechnologybiotechnologydrug-deliverypharmaceuticalsbiodegradablemental-health
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}